GlassScriptPhysician profile
Ann B Maddox
NPI 1689017832
$6,535.31
in general payments reported to CMS, 2019-2025
31 companies · $243 in 2025
The $243 reported for 2025 was more than what a typical Adult Health (Nurse Practitioner) provider received nationally (typical 2025 total: $182).
See the full distribution for Adult Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,234 · 2022: $899 · 2023: $1,395 · 2024: $2,764 · 2025: $243.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,378 · Travel and Lodging: $511 · Consulting Fee: $400 · Education: $98.99 · Gift: $14.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,377.50 |
| Travel and Lodging | $510.66 |
| Consulting Fee | $400.00 |
| Education | $98.99 |
| Gift | $14.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $1,346.23 | 2024 | |
| Actelion Pharmaceuticals US, INC. | $768.89 | 2021-2024 | Uptravi, Opsumit |
| Glaxosmithkline, LLC. | $625.81 | 2021-2024 | Trelegy Ellipta, Nucala, Arexvy |
| Bayer Healthcare Pharmaceuticals INC. | $603.89 | 2021-2025 | |
| Astrazeneca Pharmaceuticals LP | $592.22 | 2021-2024 | Tezspire, Tagrisso, Airsupra |
| Electromed, INC. | $570.20 | 2021-2025 | Smartvest |
| Grifols USA, LLC | $237.64 | 2023-2024 | Prolastin-C Liquid, Xembify |
| Amgen INC. | $229.36 | 2021-2024 | Tezspire |
| Mylan Specialty L.P. | $198.30 | 2021-2024 | Yupelri |
| United Therapeutics Corporation | $176.00 | 2021-2024 | Tyvaso |
| Takeda Pharmaceuticals U.S.A., INC. | $156.99 | 2022-2024 | Glassia |
| Boehringer Ingelheim Pharmaceuticals, INC. | $149.39 | 2021-2023 | Stiolto Respimat |
| Merck Sharp & Dohme LLC | $130.55 | 2022-2024 | Winrevair |
| Regeneron Healthcare Solutions, INC. | $117.68 | 2022-2024 | Dupixent |
| Genzyme Corporation | $106.24 | 2021-2024 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ani Pharmaceuticals, INC. | $87.71 | 2024 | Purified Cortrophin Gel |
| Alexion Pharmaceuticals, INC. | $73.46 | 2021 | |
| Baxter Healthcare | $57.06 | 2022-2024 | Hillrom - Vest System Model 105 Home Care |
| Chiesi USA, INC. | $36.54 | 2022-2024 | Kengreal, Cleviprex |
| E.R. Squibb & Sons, L.L.C. | $34.51 | 2021 | |
| Ethicon INC. | $34.22 | 2021 | |
| Insmed, INC. | $28.18 | 2023 | Arikayce |
| Inogen, INC. | $27.75 | 2023 | Inogen One G5 Oxygen Concentrator - Bluetooth |
| Mallinckrodt Hospital Products INC. | $26.63 | 2021 | |
| Xeris Pharmaceuticals, INC. | $20.32 | 2022 | |
| Janssen Pharmaceuticals, INC | $19.11 | 2022 | |
| Phadia US INC. | $18.98 | 2022 | |
| Paratek Pharmaceuticals, INC. | $18.11 | 2024 | Nuzyra |
| Genentech USA, INC. | $16.84 | 2021 | |
| Novartis Pharmaceuticals Corporation | $14.32 | 2023 | |
| Philips North America LLC | $12.18 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ann Maddox listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.